Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery

Area of Science:

• Nanotechnology
• Materials Science
• Pharmaceutical Sciences

Background:

• Solid lipid nanoparticles (SLNs) are composed of active drug molecules, solid lipids, and surfactants.
• SLNs offer nano-size, functionalizable surfaces for ligand attachment, and safe encapsulation of both lipophilic and hydrophilic compounds.

Purpose of the Study:

• To review the synthesis, characterization, and applications of solid lipid nanoparticles (SLNs).
• To highlight the potential of SLNs in targeted drug delivery, particularly for cancer therapy.

Main Methods:

• SLNs can be synthesized using techniques like homogenization, spray drying, ultrasonication, and emulsification.
• Characterization involves assessing particle size, polydispersity index, surface morphology, and thermal properties (DSC, XRD).

Main Results:

• SLNs exhibit good stability and surface modifiability for targeted delivery.
• Applications span various administration routes including oral, parenteral, topical, and pulmonary.
• SLNs show promise in gene/DNA delivery, vaccines, and cosmeceuticals.

Conclusions:

• Solid lipid nanoparticles (SLNs) are a promising nanomaterial for efficient delivery of diverse active pharmaceutical ingredients (APIs).
• Their versatility makes them suitable for a wide range of therapeutic and cosmetic applications.